Investment analysts at Sanford C. Bernstein initiated coverage on shares of Revvity (NYSE:RVTY – Get Free Report) in a report issued on Thursday, FlyOnTheWall reports. The firm set an “outperform” rating on the stock.
A number of other equities research analysts also recently issued reports on the company. Robert W. Baird lowered their price target on Revvity from $165.00 to $147.00 and set an “outperform” rating for the company in a research report on Wednesday, August 2nd. Barclays boosted their target price on Revvity from $125.00 to $130.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 2nd. JPMorgan Chase & Co. raised their price target on shares of Revvity from $120.00 to $130.00 and gave the company a “neutral” rating in a report on Wednesday, August 2nd. Finally, Raymond James started coverage on shares of Revvity in a research note on Tuesday, July 18th. They set an “outperform” rating and a $145.00 price objective for the company. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Revvity currently has an average rating of “Moderate Buy” and an average target price of $138.00.
Revvity Price Performance
Shares of RVTY stock opened at $109.05 on Thursday. The business’s 50-day moving average is $117.22. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.26 and a current ratio of 2.58. Revvity has a 1-year low of $105.82 and a 1-year high of $150.17. The stock has a market cap of $13.54 billion, a price-to-earnings ratio of 16.67 and a beta of 1.08.
Revvity (NYSE:RVTY – Get Free Report) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.02. Revvity had a net margin of 29.19% and a return on equity of 9.06%. The company had revenue of $709.10 million for the quarter, compared to the consensus estimate of $708.61 million. During the same quarter last year, the firm posted $2.32 earnings per share. Revvity’s revenue was down 20.8% on a year-over-year basis. Analysts expect that Revvity will post 4.78 earnings per share for the current fiscal year.
Revvity Company Profile
Revvity, Inc provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.